ArticleBiochemistry and biophysics reports2025
An integrated environmental toxicity risk assessment framework combining deep learning and molecular simulation: A case study on pyrethrins and breast cancer.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study develops and validates a multi-scale integrative computational toxicology framework to systematically investigate the potential association between the natural pesticides pyrethrin I and II and breast cancer risk. The proposed approach integrates deep learning-based drug-target interaction prediction (via DeepPurpose), molecular docking and dynamics (MD) simulations, and protein-protein interaction (PPI) network modeling, forming a traceable risk inference chain from molecular-level interactions to clinically relevant outcomes. Experimental results revealed that pyrethrin I exhibits stable and high-affinity binding to key breast cancer-related proteins, including RPS6KB1, TNKS2, and MAOB, with a minimum binding free energy (ΔG) reaching -27.37 kcal/mol. These interactions potentially modulate tumor progression through key oncogenic pathways such as PI3K/AKT, Wnt/β-catenin, and metabolic reprogramming. RPS6KB1 is implicated in estrogen receptor-positive (ER+) breast cancer proliferation, while TNKS2 is closely associated with stemness maintenance and the aggressiveness of triple-negative breast cancer (TNBC). MAOB demonstrates the highest structural stability among complexes, making it a promising candidate for toxicological modeling. The study further introduces a cross-scale risk indicator modeling strategy, constructing a mechanistically interpretable chain from compound structure to protein modules, carcinogenic pathways, and clinical risks. This integrative methodology supports environmental exposure monitoring and toxicological policy development. The open-source, containerized analytical toolchain developed herein is highly extensible and adaptable for future toxicological evaluations of other natural compounds and emerging environmental pollutants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.